Hillstream BioPharma Provides Webcast for its R&D Day on February 14th, 2023 at…
<!-- Name:DistributionId Value:8748207 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Webcast
NanoXplore Inc. to Host Second Quarter 2023 Results Webcast on February 15, 2023
Article content MONTREAL, Jan. 31, 2023 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or the “Company”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of…
Galantas Gold to Present on Geology and District-Scale Potential of the Gairloch…
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients.…
HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery…
TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative…
Brookfield Business Partners L.P. 2022 Fourth Quarter Conference Call and Webcast for…
Article content Date: Friday, February 3, 2023Time: 11:00 a.m. (Eastern Time) BROOKFIELD NEWS, Dec. 23, 2022 (GLOBE NEWSWIRE) — You are invited to participate in Brookfield Business…
Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12,…
BURLINGAME, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that…
Yield10 Bioscience Announces Third Quarter 2022 Financial Results
-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track-Collaboration with Rothamsted Research for omega-3 technology extended…
Arbutus to Present at Jefferies London Healthcare Conference
WARMINSTER, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to…
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter…
BURNABY, British Columbia, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will report its…
Cyclacel Hosting Research & Development Day
-Program Update on its CDK2/9 Inhibitor, Oral Fadraciclib, and Oral PLK1 Inhibitor, CYC140, for the Treatment of Advanced Solid Tumors and Lymphoma- -Monday, October 31st @ 10 am ET-…